Furthermore, complex Immunomodulatory Therapies: like Intravenous Immunoglobulin (IVIg) are delivered via IV to treat autoimmune and inflammatory diseases, working through intricate mechanisms to modulate the immune system
#Tirzepatide acts as a dual agonist of #GIP (glucose-dependent insulinotropic polypeptide) and #GLP-1 (glucagon-like peptide-1) receptors, whereas semaglutide is a selective GLP-1 receptor agonist
It's not just about burning calories
These extensive neuromodulatory effects indicate its potential as a supplementary treatment for intricate, multifactorial CNS disorders
Obesity is recognized by major medical organizations as a chronic, relapsing disease, which means care decisions should be individualized and approached with a long term mindset rather than treated as a short term fix
Bottom line: Oral GLP-1 supplements have a more substantiated evidence base than patches